📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
57
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GFR.
💹 Market Data
Market Cap$726.23M
Shares Outstanding125.43M
Float33.64M
Cash$394.1K
Debt$6.80M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 29.1% shares (2025Q4 vs prior)
39 institutional holders · 11.87M shares
#1
Nokomis Capital, L.L.C.
2.11M shares
#2
WEXFORD CAPITAL LP
2.03M shares
#3
Moerus Capital Management LLC
1.69M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest38.4K
Days to Cover1.0
% of Float0.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for GFR
📊 GFR FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 GFR Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.